NCT03222531View on ClinicalTrials.gov

Expanding the Pool in Orthotopic Heart Transplantation

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Hepatitis CHeart TransplantCardiac Transplant

Interventions

DRUG

sofosbuvir/velpatasvir

Drug: sofobuvir/velpatasvir

Trial Locations (1)

15213

UPMC, Pittsburgh

All Listed Sponsors

lead

Mary E. Keebler, MD

OTHER